DEFEROXAMINE MESILATE ( DrugBank: Deferoxamine )

1 disease

ID	Disease name (Link within this page)	Number of trials
286	Hereditary sideroblastic anemia	2

286. Hereditary sideroblastic anemia

Clinical trials : 7 / Drugs : 23 - (DrugBank : 10) / Drug target genes : 8 - Drug target pathways : 42

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-021062-29-GR (EUCTR)	12/04/2011	02/02/2011	Phase II, open-label, single-arm, multicenter study to evaluate the efficacy and safety of deferasir ...	Phase II, open-label, single-arm, multicenter study to evaluate the efficacy and safety of deferasir ...	transfusion-dependent patients with TM, DBA or congenital sideroblastic anemia with severe cardiac i ...	Trade Name: Exjade Product Name: Exjade Product Code: ICL670 INN or Proposed INN: DEFERASIROX Other desc ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	45	Phase 2	Greece;Italy;United Kingdom
2	EUCTR2010-021062-29-GB (EUCTR)	21/12/2010	20/10/2010	Phase II, open-label, single-arm, multicenter study to evaluate the efficacy and safety of deferasir ...	Phase II, open-label, single-arm, multicenter study to evaluate the efficacy and safety of deferasir ...	transfusion-dependent patients with TM, DBA or congenital sideroblastic anemia with severe cardiac i ...	Trade Name: Exjade Product Name: Exjade Product Code: ICL670 INN or Proposed INN: DEFERASIROX Other desc ...	Novartis Pharma Services AG	NULL	Not Recruiting			Female: yes Male: yes	45	Phase 2	Greece;Italy;United Kingdom

First Previous1Next Last